NervGen Pharma Corp. NGEN.V Stock
NervGen Pharma Corp. Price Chart
NervGen Pharma Corp. NGEN.V Financial and Trading Overview
| NervGen Pharma Corp. stock price | 2.16 CAD |
| Previous Close | 1.71 CAD |
| Open | 1.72 CAD |
| Bid | 1.7 CAD x 0 |
| Ask | 1.72 CAD x 0 |
| Day's Range | 1.7 - 1.73 CAD |
| 52 Week Range | 1.5 - 2.6 CAD |
| Volume | 24.5K CAD |
| Avg. Volume | 20.16K CAD |
| Market Cap | 101.84M CAD |
| Beta (5Y Monthly) | 1.635902 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.33 CAD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 5.25 CAD |
NGEN.V Valuation Measures
| Enterprise Value | 83.49M CAD |
| Trailing P/E | N/A |
| Forward P/E | -1.6380954 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 10.299401 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -3.68 |
Trading Information
NervGen Pharma Corp. Stock Price History
| Beta (5Y Monthly) | 1.635902 |
| 52-Week Change | 13.15% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 2.6 CAD |
| 52 Week Low | 1.5 CAD |
| 50-Day Moving Average | 1.67 CAD |
| 200-Day Moving Average | 1.79 CAD |
NGEN.V Share Statistics
| Avg. Volume (3 month) | 20.16K CAD |
| Avg. Daily Volume (10-Days) | 9.23K CAD |
| Shares Outstanding | 59.21M |
| Float | 46.3M |
| Short Ratio | 0.08 |
| % Held by Insiders | 21.64% |
| % Held by Institutions | 0.0060% |
| Shares Short | 1.72K |
| Short % of Float | N/A |
| Short % of Shares Outstanding | 0% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -86.14% |
| Return on Equity (ttm) | -180.65% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -22688828 CAD |
| Net Income Avi to Common (ttm) | -20463732 CAD |
| Diluted EPS (ttm) | -0.36 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 18.02M CAD |
| Total Cash Per Share (mrq) | 0.3 CAD |
| Total Debt (mrq) | 262.37K CAD |
| Total Debt/Equity (mrq) | 2.66 CAD |
| Current Ratio (mrq) | 2.035 |
| Book Value Per Share (mrq) | 0.167 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -18338340 CAD |
| Levered Free Cash Flow (ttm) | -3648067 CAD |
Profile of NervGen Pharma Corp.
| Country | Canada |
| State | BC |
| City | Vancouver |
| Address | 2955 Virtual Way |
| ZIP | V5M 4X6 |
| Phone | 778-731-1711 |
| Website | https://www.nervgen.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
NervGen Pharma Corp., together with its subsidiaries, engages in the discovery, development, and commercialization of pharmaceutical treatments for medical conditions related to nervous system damage. The company's lead product candidate is NVG-291 that is in phase 1 clinical trial for the treatment of spinal cord injuries (SCI), multiple sclerosis, and Alzheimer's disease. It has a licensing agreement with Case Western Reserve University to research, develop, and commercialize a patented technology with therapeutic potential for SCI and other conditions associated with nerve damage. The company was incorporated in 2017 and is based in Vancouver, Canada.
Q&A For NervGen Pharma Corp. Stock
What is a current NGEN.V stock price?
NervGen Pharma Corp. NGEN.V stock price today per share is 2.16 CAD.
How to purchase NervGen Pharma Corp. stock?
You can buy NGEN.V shares on the TSXV exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for NervGen Pharma Corp.?
The stock symbol or ticker of NervGen Pharma Corp. is NGEN.V.
Which industry does the NervGen Pharma Corp. company belong to?
The NervGen Pharma Corp. industry is Biotechnology.
How many shares does NervGen Pharma Corp. have in circulation?
The max supply of NervGen Pharma Corp. shares is 69.93M.
What is NervGen Pharma Corp. Price to Earnings Ratio (PE Ratio)?
NervGen Pharma Corp. PE Ratio is now.
What was NervGen Pharma Corp. earnings per share over the trailing 12 months (TTM)?
NervGen Pharma Corp. EPS is -0.33 CAD over the trailing 12 months.
Which sector does the NervGen Pharma Corp. company belong to?
The NervGen Pharma Corp. sector is Healthcare.